Left Ventricular Dysfunction:治療薬開発パイプライン分析2014

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIPR2014381)
◆英語タイトル:Left Ventricular Dysfunction-Pipeline Insights, 2014
◆発行会社/調査会社:DelveInsight
◆商品コード:DIPR2014381
◆発行日:2014年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬、医療
◆ページ数:※お問い合わせください。
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥141,250見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[Left Ventricular Dysfunction:治療薬開発パイプライン分析2014]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s,“ Left Ventricular Dysfunction-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Left Ventricular Dysfunction. This report provides information on the therapeutic development based on the Left Ventricular Dysfunction dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.


Scope
• The report provides a snapshot of the global therapeutic landscape of Left Ventricular Dysfunction
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Left Ventricular Dysfunction pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Left Ventricular Dysfunction and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


Reasons to buy
• Complete Pipeline intelligence and complete understanding over therapeutics development for Left Ventricular Dysfunction
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
• Devise corrective measures for pipeline projects by understanding Left Ventricular Dysfunction pipeline depth and focus of Indication therapeutics
• Developing strategic initiatives to support your drug development activities.
• Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
• Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
• Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
• Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions


*** レポート目次(コンテンツ)***

Table of Contents
• Left Ventricular Dysfunction Overview
• Left Ventricular Dysfunction Pipeline Therapeutics
• Left Ventricular Dysfunction Therapeutics under Development by Companies
• Left Ventricular Dysfunction Late Stage Products (Filed and Phase III)
• Comparative Analysis
• Left Ventricular Dysfunction Mid Clinical Stage Products (Phase II)
• Comparative Analysis
• Left Ventricular Dysfunction Early Clinical Stage Products (Phase I and IND Filed)
• Comparative Analysis
• Left Ventricular Dysfunction Discovery and Pre-Clinical Stage Products
• Comparative Analysis
• Drug Candidate Profiles
• Left Ventricular Dysfunction – Therapeutics Assessment
• Assessment by Monotherapy Products
• Assessment by Combination Products
• Assessment by Route of Administration
• Assessment by Molecule Type
• Left Ventricular Dysfunction – Discontinued Products
• Left Ventricular Dysfunction – Dormant Products
• Companies Involved in Therapeutics Development for Left Ventricular Dysfunction
• Appendix
• Methodology
• Contact Us
• Disclaimer

List of Tables
• Number of Products under Development for Left Ventricular Dysfunction, 2014
• Number of Products under Development by Companies
• Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
• Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
• Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
• Drug Candidates Profiles
• Left Ventricular Dysfunction Assessment by Monotherapy Products
• Left Ventricular Dysfunction Assessment by Combination Products
• Left Ventricular Dysfunction Assessment by Route of Administration
• Left Ventricular Dysfunction Assessment by Stage and Route of Administration
• Left Ventricular Dysfunction Assessment by Molecule Type
• Left Ventricular Dysfunction Assessment by Stage and Molecule Type
• Left Ventricular Dysfunction Therapeutics – Discontinued Products
• Left Ventricular Dysfunction Therapeutics – Dormant Products
• Products under Development by Companies, 2014


List of Figures
• Number of Products under Development for Left Ventricular Dysfunction, 2014
• Late Clinical Stage Products (Filed and Phase III), 2014
• Mid Clinical Stage Products (Phase II), 2014
• Early Clinical Stage Products (Phase I and IND Filed), 2014
• Discovery and Pre-Clinical Stage Products, 2014
• Left Ventricular Dysfunction Assessment by Monotherapy Products
• Left Ventricular Dysfunction Assessment by Combination Products
• Left Ventricular Dysfunction Assessment by Route of Administration
• Left Ventricular Dysfunction Assessment by Stage and Route of Administration
• Left Ventricular Dysfunction Assessment by Molecule Type
• Left Ventricular Dysfunction Assessment by Stage and Molecule Type


*** レポートのキーワード ***

Left Ventricular Dysfunction、病、治療薬、研究開発、パイプライン、製薬企業、臨床、医薬品

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 世界の移動足場市場2017
    Movable Scaffold Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germa …
  • 世界及び中国のマッサージクッション市場2017
    The 'Global and Chinese Massage Cushion Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Massage Cushion industry with a focus on the Chinese market. The report provides key statistics on the market status of the Massage Cushion manu …
  • スマートポリマーの世界市場2016
    Notes:Production, means the output of Smart Polymer Revenue, means the sales value of Smart Polymer This report studies Smart Polymer in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, productio …
  • フタル酸ジ(2-エチルヘキシル)の世界市場2018
    The Global Bis(2-Ethylhexyl)Phthalate (CAS 117-81-7) Industry 2018 Market Research Report is a professional and in-depth study on the current state of the Bis(2-Ethylhexyl)Phthalate industry. Firstly, the report provides a basic overview of the industry including definitions, classifications, applic …
  • 肺動脈性肺高血圧症(PAH)の疫学予測
    DelveInsight’s ‘Pulmonary Arterial Hypertension - Epidemiology Forecast to 2027’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Pulmonary Arterial Hypertension in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan. …
  • 電動搾乳器の世界市場
    About Electric Breast Pumps An electrical device powered by electricity from the grid or batteries and used for extracting milk from the breasts of a lactating woman is known as an electrical breast pump. The device assists in triggering the milk ejection response or let-down reflex of lactating mot …
  • カーボンナノチューブの世界市場予測2018-2026
    KEY FINDINGSThe Global Carbon Nanotube market is expected to grow at a CAGR of 17.69% during the forecast years of 2018-2026.Technological advancements in the field of CNT through continuous R&D, high conductivity as well as their properties of high tensile strength, low density, and transparency ar …
  • パキスタンの肥料混合物市場(~2019)
    The industry report Fertilizer Mixture Market in Pakistan to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for fertilizer mixtures in Pakistan. The research includes historic market data from 2008 to 2014 and …
  • 世界のハイバリアパウチ市場2016
    Notes:Production, means the output of High-Barrier Pouches Revenue, means the sales value of High-Barrier Pouches This report studies High-Barrier Pouches in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, wit …
  • 世界のジフルニサルホスフェート市場2017
    Diflunisal Phosphate Market Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United St …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIPR2014381 )"Left Ventricular Dysfunction:治療薬開発パイプライン分析2014" (英文:Left Ventricular Dysfunction-Pipeline Insights, 2014)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。